.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeMarket Insights Snapshot
In October 2026, Karma Originals concentrated 42.81% of sales in Pre-Roll with a year-over-year decline of 89.64% and a month-over-month drop of 34.38%, while Concentrates held 40.57% share with a 36.93% YoY contraction and a 7.85% MoM decline. Flower surged to 13.51% share on a 4,355.51% MoM spike despite no YoY baseline, and Vapor Pens accounted for 3.12% share with a 65.86% YoY decline offset by an 84.64% MoM increase. The mix implies a pivot away from the historically dominant Pre-Roll segment toward categories with faster near-term momentum, particularly Flower and Vapor Pens, meaning short-term gains are being driven by volatility rather than entrenched category strength.
Average price rose 19.89% YoY to $17.53 while the top category’s average price sat at $16.19, signaling a price-led repositioning above Pre-Roll norms as sales fell 79.45% YoY at the brand level. In Nevada Pre-Roll, Karma Originals ranked 64, and Concentrates now commands 40.57% of brand mix against Pre-Roll’s 42.81%, indicating a narrowing gap that could reframe the brand’s core identity if the 7.85% MoM decline in Concentrates stabilizes and the 34.38% MoM contraction in Pre-Roll persists. The pattern implies that brand positioning will increasingly hinge on managing margin and price architecture around Concentrates and opportunistic Flower surges, rather than relying on Pre-Roll volume recovery.
Competitive Landscape
Karma Originals sits at rank #64 in NV Pre-Roll in October 2026, down 50 positions year over year from #14 and 43 positions lower than its July 2026 mark of #21, while the brand’s peak of #7 in January 2026 contrasts with a multi-quarter slide. In the same period, Rove moved to #1 from #4 year over year alongside a 77.2% sales increase, and STIIIZY held at #2 after a smaller rank shift of +1 despite a 20.9% sales decline; these competitor trajectories indicate that Karma Originals’ rank erosion is driven less by category contraction and more by share being reallocated toward a top-tier gainer. The pattern implies Karma Originals is losing relevance within NV Pre-Roll assortments as distribution or velocity has narrowed relative to leaders that either climbed ranks or held top-two positions.
Notable Products
Karma Originals is highly concentrated in October 2026, with the top 10 items capturing 85.5% of sales and the leading CBG/CBN/THC 1:1:4 Calm RSO Syringe (1g) alone at 29.5%. That concentration, paired with 42.8% of sales in Connoisseur/Infused Pre-Rolls and 29.5% in RSO/Full Spectrum, means most of its sales come from a tight set of infused pre-rolls and one flagship RSO.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
